VANGUARD HEALTH SYSTEMS INC's gross profit margin for the fourth quarter of its fiscal year 2013 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. VANGUARD HEALTH SYSTEMS INC has average liquidity. Currently, the Quick Ratio is 1.33 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.
At the same time, stockholders' equity ("net worth") has greatly increased by 33.17% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY13||Q4 FY12|
|Net Sales ($mil)||1517.5||1454.8|
|Net Income ($mil)||14.5||19.3|
|Balance Sheet||Q4 FY13||Q4 FY12|
|Cash & Equiv. ($mil)||630.5||457.9|
|Total Assets ($mil)||5042.6||4788.1|
|Total Debt ($mil)||2996.2||2706.6|
|Profitability||Q4 FY13||Q4 FY12|
|Gross Profit Margin||10.1||11.24|
|Return on Assets||1.22||1.19|
|Return on Equity||15.72||19.58|
|Debt||Q4 FY13||Q4 FY12|
|Share Data||Q4 FY13||Q4 FY12|
|Shares outstanding (mil)||77.9||75.47|
|Div / share||0.0||0.0|
|Book value / share||5.04||3.91|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||459895.0||756528.0|
HOLD. VANGUARD HEALTH SYSTEMS INC's P/E ratio indicates a premium compared to an average of 22.83 for the Health Care Providers & Services industry and a premium compared to the S&P 500 average of 19.37. Conducting a second comparison, its price-to-book ratio of 4.16 indicates a significant premium versus the S&P 500 average of 2.46 and a premium versus the industry average of 2.71. The current price-to-sales ratio is well below the S&P 500 average and is also below the industry average, indicating a discount. After reviewing these and other key valuation criteria, VANGUARD HEALTH SYSTEMS INC proves to trade at a premium to investment alternatives within the industry.
|VHS 27.99||Peers 22.83||VHS 5.44||Peers 13.01|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
VHS is trading at a premium to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
VHS is trading at a significant discount to its peers.
|VHS 20.89||Peers 15.91||VHS 14.00||Peers 2.29|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
VHS is trading at a significant premium to its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
VHS trades at a significant premium to its peers.
|VHS 4.16||Peers 2.71||VHS 7.14||Peers 1.37|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
VHS is trading at a significant premium to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
VHS is expected to have an earnings growth rate that significantly exceeds its peers.
|VHS 0.27||Peers 0.70||VHS 0.84||Peers 18.54|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
VHS is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
VHS significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV